Published By : 23 Oct 2017 | Published By : QYRESEARCH
A new study conducted at the University of North Carolina at Chapel Hill has made interesting discoveries into the health effects of e-cigarettes on regular smokers. E-cigarettes are being branded the healthier alternative to smoking and are thus catching on at rapid rate, especially among younger smokers looking for a healthy alternative. However, the new study’s findings show that while e-cigarettes may well be less dangerous in terms of the risk posed by conventional cigarettes, vaping is not without its own share of potential concerns and may carry its own unique set of problems. E-cigarettes don’t have the carcinogenic compounds that comprise the primary threat in conventional cigarettes, but the study shows vaping may help the onset of inflammatory lung diseases by triggering an immune response in smokers’ lungs.
The study comprises of 44 sputum samples taken from e-cigarette smokers, non-smokers, and conventional cigarette smokers. The neutrophil granulocyte- and neutrophil-extracellular-trap (NET)-related protein count exhibited a significant rise in the e-cigarette smoking demographic. These proteins are useful in combating pathogens but are thus also known to be linked with diseases such as COPD and cystic fibrosis. An increased secretion of a mucus secretion known to be linked with asthma and chronic bronchitis was a common finding among the e-cigarette smokers and conventional smokers, making e-cigarettes no better in terms of reducing the likelihood of asthma.
The validity of the study is limited thanks to its small sample size as well as the presence of former cigarette smokers among the e-cigarette smoking group in the study. However, it may prove to be an important milestone in researchers learning to assess the risks of e-cigarettes on their own merit, rather than as just an alternative to cigarettes.